| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/20/2013 | CN102936337A Poly (gamma-propargyl-L-glutamate)-polyamino acid segmented copolymer, functional segmented copolymer and preparation method |
| 02/20/2013 | CN102936283A Anti-human CD146 monoclonal antibodies, compositions containing anti-human CD146 monoclonal antibodies, and soluble CD146 detection method |
| 02/20/2013 | CN102936281A RTRAIL(recombinant TNF(tumor necrosis factor) related apoptosis-inducing ligand) mutant and monomethyl auristatin E(MMAE) conjugate thereof |
| 02/20/2013 | CN102936277A Human blood vessel endothelial growth factor antigen epitope and epitope vaccine thereof |
| 02/20/2013 | CN102936257A Structures, preparation methods and uses of silver-containing thiazole Schiff's base complexes |
| 02/20/2013 | CN102936250A 稠合双环mTOR抑制剂 Fused bicyclic inhibitors of mTOR |
| 02/20/2013 | CN102936241A Homopiperony lamine pyridine-2-formaldehyde and synthetic method and application thereof |
| 02/20/2013 | CN102935239A Preparation for preventing or treating lung cancers and preparation method and application thereof |
| 02/20/2013 | CN102935238A Application of yeast M-dsRNA as TLR3 agonist, and yeast M-dsRNA preparation method |
| 02/20/2013 | CN102935237A Doxorubicin bonding medicine and preparation method thereof |
| 02/20/2013 | CN102935236A Antineoplastic prodrug with P-glycoprotein inhibition function |
| 02/20/2013 | CN102935230A Use of RNAi inhibiting PARP activtiy for the manufacture of a medicament for the treatment of cancer |
| 02/20/2013 | CN102935229A New medical application of metallic simple substances |
| 02/20/2013 | CN102935228A Reagent for tumor treatment, its use and method |
| 02/20/2013 | CN102935204A Traditional Chinese preparation for treating hysteromyoma |
| 02/20/2013 | CN102935146A Extraction method of tea polyphenols |
| 02/20/2013 | CN102935104A Maackia amurensis total flavone extract, as well as preparation method and application thereof |
| 02/20/2013 | CN102935102A Method for simultaneously producing honeysuckle flower distillate and various active substances |
| 02/20/2013 | CN102935101A Extraction method of olive leaf polyphenol |
| 02/20/2013 | CN102935099A Extractive capable of reducing insulin resistance as well as preparation method and application thereof |
| 02/20/2013 | CN102935097A Taxus compound traditional Chinese medicine having anticancer effect and preparation method thereof |
| 02/20/2013 | CN102935096A Application of camptosorus sibiricus total flavonids in preparation of medicines for preventing and treating tumour |
| 02/20/2013 | CN102935091A Propolis flavonoid extracting method |
| 02/20/2013 | CN102935080A Bendamustine cyclopolysaccharide compositions |
| 02/20/2013 | CN102935079A Pharmaceutical application of caffeic acid 3, 4-dihydroxyl phenethylester |
| 02/20/2013 | CN102935067A Stealth liposome having PVTRPPR fragment modification on surface, preparation method and uses thereof |
| 02/20/2013 | CN102935066A Irinotecan liposome preparation and preparation method thereof |
| 02/20/2013 | CN102935062A Polymeric micelle composition loaded with epothilone compound or derivatives thereof, freezed-drying preparation, and preparation and application thereof |
| 02/20/2013 | CN102198125B Purpose of phenethyl caffeate derivatives in preparation of medicines for inhibiting angiogenesis of tumors |
| 02/20/2013 | CN102180939B Ursolic acid chemical modifier with antitumor activity and preparation method thereof |
| 02/20/2013 | CN102008715B Antitumor MA-TNF alpha medicine composition and application thereof |
| 02/20/2013 | CN101903046B Constructs containing multiple expression cassettes for cancer therapy |
| 02/20/2013 | CN101836962B Method for preparing bendamustine hydrochloride freeze-dried powder injection |
| 02/20/2013 | CN101829044B Tamibarotene solid preparation and preparation method thereof |
| 02/20/2013 | CN101724019B Thymopeptide-5 active esters, medicinal composition containing same and application thereof |
| 02/20/2013 | CN101584663B Novel delivery system of Duoxitasai lipidosome for injection and preparation method thereof |
| 02/20/2013 | CN101573384B Antibodies and immunoconjugates and uses therefor |
| 02/20/2013 | CN101496845B Hedyotis diffusa Willd. extract and method for separating and preparing the same |
| 02/19/2013 | USRE44022 Cyclic peptides, method for preparing and use as angiogenesis inhibitors or activators |
| 02/19/2013 | US8378100 Phosphonate derivatives as autotaxin inhibitors |
| 02/19/2013 | US8378099 Boronic ester and acid compounds, synthesis and uses |
| 02/19/2013 | US8377981 CBI derivatives subject to reductive activation |
| 02/19/2013 | US8377968 N-piperidinyl acetamide derivatives as calcium channel blockers |
| 02/19/2013 | US8377961 Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and P53 |
| 02/19/2013 | US8377946 Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors |
| 02/19/2013 | US8377927 Compositions and methods for treatment of cancer |
| 02/19/2013 | US8377919 Therapeutic compositions |
| 02/19/2013 | US8377913 Vitamin D receptor activators and methods of making |
| 02/19/2013 | US8377897 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 02/19/2013 | US8377895 Cyclin-dependent protein kinases inhibitors of Scutellaria flavonoid organic amine derivatives, synthesis and use thereof |
| 02/19/2013 | US8377893 Highly purified antiendotoxin compound |
| 02/19/2013 | US8377888 Method of predicting the clinical response to cisplatin or carboplatin chemotherapeutic treatment |
| 02/19/2013 | US8377865 Growth hormone releasing peptides |
| 02/19/2013 | US8377645 Unc-33 like phosphoprotein (ULIP) polypeptide for generating antibodies for use in diagnosis, preventnion and treatment of neurodegenerative and neoplastic disorders |
| 02/19/2013 | US8377483 Bioactivation of iron salt, especially an ferric ferrous salt, by adding a magnesium salt (MgCl2); useful as a medicine to treat diseases such as diabetes, freshness preservative agent, and animal and plant growth promoter |
| 02/19/2013 | CA2738573C Compositions of propane-1 sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide and uses thereof |
| 02/19/2013 | CA2716856C Aurora kinase modulators and method of use |
| 02/19/2013 | CA2703257C Benzomorpholine derivatives and methods of use |
| 02/19/2013 | CA2683637C Methods for treating neoplasia with combination of chemotherapeutic agents and radiation |
| 02/19/2013 | CA2658525C Smac peptidomimetics useful as iap inhibitors |
| 02/19/2013 | CA2573371C Pyrimidines as plk inhibitors |
| 02/19/2013 | CA2487137C Tumour-associated peptides that bind to mhc molecules |
| 02/19/2013 | CA2486187C Kinase inhibitors |
| 02/19/2013 | CA2467930C Treatment of pml targeting jc virus agno |
| 02/19/2013 | CA2456551C Tumour inhibiting lanthanum compounds |
| 02/19/2013 | CA2448382C Use of hepcidin as a regulator of iron homeostasis |
| 02/19/2013 | CA2409044C Improved recrystallization processes for obtaining anhydrous optically active lansoprazole |
| 02/14/2013 | WO2013023162A2 Anti-muc1 antibodies for cancer diagnostics |
| 02/14/2013 | WO2013023119A1 JAK P13K/mTOR COMBINATION THERAPY |
| 02/14/2013 | WO2013022991A2 Methods and compositions relating to p62 for the treatment and prophylaxis of cancer |
| 02/14/2013 | WO2013022919A1 P62-zz chemical inhibitor |
| 02/14/2013 | WO2013022599A1 Improved methods and compositions for modulation of olfml3 mediated angiogenesis |
| 02/14/2013 | WO2013022519A1 Pyrido-pyrimidine derivatives |
| 02/14/2013 | WO2013022406A1 Angiopoietin-like 4 and its use in modulating cell leakiness |
| 02/14/2013 | WO2013022280A2 N1-cyclic amine-n2-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same |
| 02/14/2013 | WO2013022279A2 N1-cyclic amine-n5-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same |
| 02/14/2013 | WO2013022278A2 N1-cyclic amine-n5-substituted phenyl biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same |
| 02/14/2013 | WO2013022257A2 Composition for preventing and treating non-small cell lung cancer, containing pyrazino-triazine derivatives |
| 02/14/2013 | WO2013022157A1 Pharmaceutical composition containing fibulin-3 protein as an active ingredient for inhibiting the growth of cancer stem cells |
| 02/14/2013 | WO2013022092A1 Heptamer-type small guide nucleic acid capable of inducing apoptosis of human hematologic cancer cells |
| 02/14/2013 | WO2013022052A1 Medicinal agent for medical applications, and method for searching for novel medicinal agent |
| 02/14/2013 | WO2013022047A1 Cyclopropaneamine compound |
| 02/14/2013 | WO2013021129A2 Use of a cb1 receptor antagonist as a whitening and/or anti-browning agent for keratin material |
| 02/14/2013 | WO2013021105A2 Novel derivatives of furanones and pharmaceutical composition containing same |
| 02/14/2013 | WO2013020622A1 N-(benzimimdazol-2-yl)-cyclopropane carboxamides as lysophosphatidic acid antagonists |
| 02/14/2013 | WO2013020371A1 Pim kinase inhibitor, preparation method and use thereof in drug preparation |
| 02/14/2013 | WO2013020370A1 Pim kinase inhibitor and preparation method and use in medicinal manufacture thereof |
| 02/14/2013 | WO2013020369A1 Pim kinase inhibitor, preparation method therefor, and pharmaceutical application thereof |
| 02/14/2013 | WO2013020366A1 The use of ache as nuclease |
| 02/14/2013 | WO2013020285A1 Method for chemical synthesis of antrocin and use thereof for suppressing non-small cell lung cancer |
| 02/14/2013 | WO2013020204A1 Polymeric nanoparticles for photosensitizers |
| 02/14/2013 | WO2012174203A8 Methods and kits for the detection and treatment of recurring prostate cancer |
| 02/14/2013 | WO2012166588A3 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof |
| 02/14/2013 | WO2012143382A9 Gpr177 as target and marker in tumors |
| 02/14/2013 | US20130042334 Capping-Prone RNA Polymerase Enzymes and Their Applications |
| 02/14/2013 | US20130042333 Markers for cancer prognosis and therapy and methods of use |
| 02/14/2013 | US20130041047 Urinary Methylation Markers for Bladder Cancer |
| 02/14/2013 | US20130041027 Organo-Arsenoxide Compounds and Use Thereof |
| 02/14/2013 | US20130041022 Glyceollins Suppress Androgen-Responsive Prostate Cancer |
| 02/14/2013 | US20130041019 SDF-1 Binding Nucleic Acids |